SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Hamps Bio Ltd

BSE: 544312 NSE: ISIN: INE0QBD01018
  |   Sector:  Miscellaneous   |   Industry:  Trading

Snapshot

Q.1 Which industry/sub-sector does Hamps Bio Ltd belong to?
Hamps Bio Ltd belongs to the Miscellaneous sector, operating specifically within the Trading segment.
Q.2 Is Hamps Bio Ltd a good quality company?
Hamps Bio Ltd is a quality company, based on a 10 year financial track record.
Q.3 Is Hamps Bio Ltd undervalued or overvalued?
Hamps Bio Ltd appears Fair, as its key valuation ratios are in line with their past averages.
Q.4 Is Hamps Bio Ltd a good buy now?
Hamps Bio Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Hamps Bio Ltd?
Hamps Bio Ltd revenue growth is 2.9% for FY-2025 , which is above its 5 year CAGR of 0% , indicating faster growth.
Q.2 Gross Profit margin of Hamps Bio Ltd?
Hamps Bio Ltd Gross profit margin which is the profit after deduction of direct costs, is 11.7% for FY-2025 , which is below its 5 year median of 14% , indicating decreasing margins.
Q.3 Operating Profit Margin of Hamps Bio Ltd?
Hamps Bio Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 11.54% for FY-2025 , which is below its 5 year median of 14.86% indicating decreasing margins.
Q.4 Net Profit Margin of Hamps Bio Ltd?
Hamps Bio Ltd Net Profit Margin is 4.46% for FY-2025 , is below with its 5 year median of 6.1%, indicating decreasing margins.
Current Level Historic Median
Gross Profit Margin 11.7 14
Operating Profit Margin 11.54 14.86
Net Profit Margin 4.46 6.1
Q.5 Return on Asset of Hamps Bio Ltd?
Hamps Bio Ltd Return on Asset is 3.35%, which is below its 5 year historical median of 7.26%, indicating deteriorated asset utilization efficiency.
Q.6 Return on Equity (ROE) of Hamps Bio Ltd?
Hamps Bio Ltd Return on equity is 4.9% for FY-2025 , which is below its historical median of 21.2%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Hamps Bio Ltd?
Hamps Bio Ltd Return on capital employed is 6.73% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of Hamps Bio Ltd?
Hamps Bio Ltd Cash conversion cycle is 134 days, above its historical median of 87 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.75 1.46
ROE 4.9 21.2
ROCE 6.73 15.51
Cash Conversion Cycle 134 days 87 days
Q.9 Debt to Equity ratio of Hamps Bio Ltd?
Hamps Bio Ltd Debt-to-Equity ratio is 0.34 , which is above with the industry average of 0.03 , indicating higher debt levels in the industry.
Q.10 Debt to cash flow from operations of Hamps Bio Ltd?
Hamps Bio Ltd Debt to cash flow from operations is -1.68 , which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Hamps Bio Ltd?
Promoters hold 71.99% of the Hamps Bio Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Hamps Bio Ltd vs industry peers?
Hamps Bio Ltd revenue CAGR is 0.00% , compared to the industry median CAGR of 0% , indicating slower growth and losing its market share.
Profit Metrics
Current Level Industry Median
Revenue 6.7 13.3
Gross Profit 0.8 0.4
Operating Profit 0.8 0
Net Profit 0.3 0.3
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.75 0.5
ROE 4.9 2.03
ROCE 6.73 3.6
Cash Conversion Cycle (days) 134.36 41

Valuation & price assessment

Q.1 Stock return of Hamps Bio Ltd over the last decade?
Over the last 1 year(s), the stock has delivered a CAGR of 15.4% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price - - - 15.4%
Q.3 Valuation ratios of Hamps Bio Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 64.38 55.30 21.75
Price to Book 1.46 1.52 1.55
Price to Sales 2.87 2.47 1.87
EV to EBITDA 23.94 18.91 13.67

Check more companies

1. Aditya Infotech
2. Aegis Logistics
3. Redington
4. RRP Semiconductor
5. Honasa Consumer
6. MMTC
7. Lloyds Enterprises
8. Cello World
9. Jeena Sikho Life
10. Elitecon Internation
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×